Page last updated: 2024-10-26

racemetirosine and Substance Withdrawal Syndrome

racemetirosine has been researched along with Substance Withdrawal Syndrome in 12 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
"Morphine was given subcutaneously 3 times daily for 5 days followed by 1 or 3 days' withdrawal."1.29Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine. ( Ahtee, L; Airio, J; Attila, M, 1995)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19908 (66.67)18.7374
1990's3 (25.00)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCann, UD1
Peterson, SC1
Ricaurte, GA1
Tagashira, E2
Hiramori, T2
Urano, T2
Yanaura, S2
Attila, LM3
Ahtee, L4
Kovács, GL2
Telegdy, G2
Hódi, K1
Nakao, K1
Acsai, L1
Tihanyi, A1
Etemadzadeh, E2
Airio, J1
Attila, M1
Caldecott-Hazard, S1
Mazziotta, J1
Phelps, M1

Other Studies

12 other studies available for racemetirosine and Substance Withdrawal Syndrome

ArticleYear
The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:8

    Topics: Adult; alpha-Methyltyrosine; Analysis of Variance; Cognition; Computer-Assisted Instruction; Electro

2007
Formation of physical dependence on barbiturates and cerebral monoamines.
    Japanese journal of pharmacology, 1983, Volume: 33, Issue:2

    Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Biogenic Amines; Body Weight; Brain; Catechol

1983
Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1984, Volume: 327, Issue:3

    Topics: alpha-Methyltyrosine; Animals; Body Weight; Brain; Brain Stem; Corpus Striatum; Diencephalon; Humans

1984
Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1984, Volume: 327, Issue:3

    Topics: alpha-Methyltyrosine; Animals; Brain; Brain Stem; Corpus Striatum; Diencephalon; Dopamine; Humans; K

1984
Drugs affecting brain dopamine interfere with the effect of Z-prolyl-D-leucine on morphine withdrawal.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 21, Issue:3

    Topics: alpha-Methyltyrosine; Animals; Brain Chemistry; Dipeptides; Dopamine; Humans; Male; Methyltyrosines;

1984
Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Life sciences, 1983, Apr-04, Volume: 32, Issue:14

    Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Humans; Mal

1983
Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
    European journal of pharmacology, 1983, Sep-30, Volume: 93, Issue:3-4

    Topics: alpha-Methyltyrosine; Animals; Brain; Catecholamines; Dopamine; Drug Tolerance; Humans; Male; Methyl

1983
Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Medical biology, 1983, Volume: 61, Issue:5

    Topics: alpha-Methyltyrosine; Animals; Brain; Catecholamines; Dopamine; Drug Interactions; Drug Tolerance; H

1983
Cerebral dopamine and noradrenaline in mice withdrawn from repeated morphine treatment and development of tolerance to a test dose of morphine.
    General pharmacology, 1994, Volume: 25, Issue:4

    Topics: alpha-Methyltyrosine; Animals; Brain Chemistry; Dopamine; Drug Tolerance; Male; Methyltyrosines; Mic

1994
Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: alpha-Methyltyrosine; Animals; Brain Chemistry; Dopamine; Drug Tolerance; Male; Methyltyrosines; Mic

1993
Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine.
    Pharmacology & toxicology, 1995, Volume: 77, Issue:3

    Topics: alpha-Methyltyrosine; Analysis of Variance; Animals; Brain Stem; Chromatography, High Pressure Liqui

1995
Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1988, Volume: 8, Issue:6

    Topics: alpha-Methyltyrosine; Amphetamine; Animals; Autoradiography; Behavior, Animal; Brain; Carbon Radiois

1988